Molecular pharmaceutical company MDNA Life Sciences has selected Phi Life Sciences to distribute its MD Mitomic Test , a proprietary liquid ##ity test for prostate cancer . The founders of MDNA Life Sciences said the partnership will help build the company 's customer base more quickly and accelerate market adoption .
Molecular diagnostics company MDNA Life Sciences has selected Phi Life Sciences to distribute its Prostate Mitomic Test, a proprietary liquid biopsy test for prostate cancer. The CEO of MDNA Life Sciences said the partnership will help build the product's user base more quickly and encourage market adoption.